에 대한 최신 뉴스 Yum China Holdings (NYSE:YUMC) 주식

Yum China Holdings

With more than 16,000 units and almost USD 12 billion in systemwide sales in 2024, Yum China is the largest restaurant operator in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (11,648 units) and Pizza Hut (3,724), but the company's portfolio also includes other brands such as Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza (collectively representing more than 1,000 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.

Meta Platforms Inc. (META)

Equities

Large Cap

Movers

BURL

CRWV

NVDA

RDDT

SMCI

YUMC

유나이티드헬스, 메타 등 지난주 부활절 주간에 급락한 대형주 11종목 (4월 14~18일)

Prague,,Czech,Republic,08,27,2024:,Temu,App,Online,Marketplace

News

Topics

Trading Ideas

APTV

BABA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

STLA

PDD홀딩스·알리바바 등 미중 무역 긴장 속 지난주 급락한 대형주 10종목: 4월 7일부터 11일까지 지난주 최악의 실적을 기록한 대형주는 다음과 같다.

PDD홀딩스·알리바바 등 미중 무역 긴장 속 지난주 급락한 대형주 10종목 (4월 7일~11일)

Tesla Inc. TSLA

BF/B

CVNA

Fomento Economico Mexicano S.A.B. De C.V.

KNSL

SOFI

TCOM

TSLA

이들 9개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 카바나(NYSE:CVNA)의 주가는 20.93% 급락했다. 공매도 업체인 힌덴버그 리서치의 비판적인 보고서는 Carvana의 회복을 &#34;신기루&#34;로 묘사하면서 약세 정서를 강화했다.

테슬라, 소파이 및 주류 주식이 지난주 최악의 성과를 보인 9개 대형주 중 일부 (12월 30일-1월 3일)

Yum China Holdings Inc

Leerink Partners analyst Andrew Berens maintains Nuvalent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVL#NASDAQ">NUVL</a>) with a Outperform and raises the price target from $125 to $140.

Price Target

Analyst Ratings

NUVL

Leerink Partners Maintains Outperform on Nuvalent, Raises Price Target to $140

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintains Nuvalent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVL#NASDAQ">NUVL</a>) with a Buy and raises the price target from $110 to $130.

HC Wainwright & Co. Maintains Buy on Nuvalent, Raises Price Target to $130

Culp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CULP#NYSE">CULP</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-06-25. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Culp will report an earnings per share (EPS) of $0.05.
Culp bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings Track Record</h3>
Last quarter the company missed EPS by $0.09, which was followed by a 12.35% drop in the share price the next day.

<img src="https://www.benzinga.com/files/images/story/2025/1750777370_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Culp were trading at $3.78 as of June 23. Over the last 52-week period, shares are down 13.16%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/CULP/earnings">To track all earnings releases for Culp visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

CULP

Culp Earnings Preview

Disclosed on June 23, CARY MCMILLAN, Director at Hyatt Hotels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: MCMILLAN's decision to sell 1,000 shares of Hyatt Hotels was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001468174/000146817425000079//Archives/edgar/data/1468174/000146817425000079/0001468174-25-000079-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The total value of the sale is $132,700.
The latest market snapshot at Tuesday morning reveals Hyatt Hotels shares up by 0.17%, trading at $132.88.
<h3>Unveiling the Story Behind Hyatt Hotels</h3>
Hyatt is an operator of owned (3% of total rooms) and managed and franchised (97%) properties across about 30 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 63% Americas, 15% rest of world, and 22% Asia-Pacific.
<h3>Unraveling the Financial Story of Hyatt Hotels</h3>
Revenue Growth: Hyatt Hotels displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 0.23%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 19.32%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Hyatt Hotels exhibits below-average bottom-line performance with a current EPS of 0.2.
</li>
</ul>
Debt Management: Hyatt Hotels's debt-to-equity ratio is below the industry average at 1.33, reflecting a lower dependency on debt financing and a more conservative financial approach.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 16.77 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 2.0, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 9.45, Hyatt Hotels could be considered undervalued.
</li>
</ul>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001468174">Check Out The Full List Of Hyatt Hotels's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

CARY MCMILLAN Takes Money Off The Table, Sells $132K In Hyatt Hotels Stock

On June 23, a substantial insider purchase was made by William F. Hulse as attorney-in-fact Dorothy Puhy, Board Member at MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>), as per the latest SEC filing.
What Happened: In a Form 4 filing on Monday with the <a href="https://www.sec.gov/Archives/edgar/data/0001376339/000137633925000061//Archives/edgar/data/1376339/000137633925000061/0001376339-25-000061-index.htm">U.S. Securities and Exchange Commission</a>, it was disclosed that Puhy bought 28,609 shares of MiMedx Group, amounting to a total of $185,100.
Tracking the Tuesday's morning session, MiMedx Group shares are trading at $5.94, showing a down of 0.0%.
<h3>Unveiling the Story Behind MiMedx Group</h3>
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin &amp; bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
<h3>Understanding the Numbers: MiMedx Group's Finances</h3>
Revenue Growth: MiMedx Group displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 4.13%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 81.23%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): MiMedx Group's EPS is below the industry average. The company faced challenges with a current EPS of 0.05. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: MiMedx Group's debt-to-equity ratio is below the industry average at 0.09, reflecting a lower dependency on debt financing and a more conservative financial approach.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 22.0 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 2.51 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Boasting an EV/EBITDA ratio of 12.71, MiMedx Group demonstrates a robust market valuation, outperforming industry benchmarks.
</li>
</ul>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001376339">Check Out The Full List Of MiMedx Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MDXG

Eye On Growth: William F. Hulse as attorney-in-fact Dorothy Puhy Adds $185K Of MiMedx Group Stock To Portfolio

A notable insider purchase on June 23, was reported by Tiffany Olson, Board Member at MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>), based on the most recent SEC filing.
What Happened: Olson made a significant move by purchasing 28,609 shares of MiMedx Group as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001376339/000137633925000064//Archives/edgar/data/1376339/000137633925000064/0001376339-25-000064-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $185,100.
MiMedx Group shares are trading down 0.0% at $5.94 at the time of this writing on Tuesday morning.
<h3>Delving into MiMedx Group's Background</h3>
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin &amp; bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
<h3>MiMedx Group: A Financial Overview</h3>
Revenue Growth: MiMedx Group's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 4.13%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 81.23%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): MiMedx Group's EPS is below the industry average. The company faced challenges with a current EPS of 0.05. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: MiMedx Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.09.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 22.0 is lower than the industry average, implying a discounted valuation for MiMedx Group's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 2.51 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 12.71, MiMedx Group demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001376339">Check Out The Full List Of MiMedx Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Bullish Move: Tiffany Olson Shows Confidence, Acquires $185K In MiMedx Group Stock

In a recent SEC filing, it was revealed that Cato T Laurencin, Director at MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>), made a noteworthy insider purchase on June 23,.
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001376339/000137633925000066//Archives/edgar/data/1376339/000137633925000066/0001376339-25-000066-index.htm">U.S. Securities and Exchange Commission</a> on Monday, Laurencin increased their investment in MiMedx Group by purchasing 28,609 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $185,100.
Tracking the Tuesday's morning session, MiMedx Group shares are trading at $5.94, showing a down of 0.0%.
<h3>Delving into MiMedx Group's Background</h3>
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin &amp; bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
<h3>Key Indicators: MiMedx Group's Financial Health</h3>
Revenue Growth: MiMedx Group's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 4.13%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 81.23%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): MiMedx Group's EPS reflects a decline, falling below the industry average with a current EPS of 0.05.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.09.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 22.0, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 2.51, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio of 12.71, the company's market valuation exceeds industry averages.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Unlocking the Meaning of Transaction Codes</h3>
In the domain of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their focus to those taking place in the open market, as meticulously outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001376339">Check Out The Full List Of MiMedx Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Director Of MiMedx Group Makes $185K Buy

It was revealed in a recent SEC filing that William A Hawkins, Board Member at MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>) made a noteworthy insider purchase on June 23,.
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001376339/000137633925000068//Archives/edgar/data/1376339/000137633925000068/0001376339-25-000068-index.htm">U.S. Securities and Exchange Commission</a> on Monday, Hawkins increased their investment in MiMedx Group by purchasing 28,609 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $185,100.
MiMedx Group's shares are actively trading at $5.94, experiencing a down of 0.0% during Tuesday's morning session.
<h3>Delving into MiMedx Group's Background</h3>
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin &amp; bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
<h3>MiMedx Group's Economic Impact: An Analysis</h3>
Revenue Growth: MiMedx Group displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 4.13%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 81.23%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): MiMedx Group's EPS reflects a decline, falling below the industry average with a current EPS of 0.05.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.09, MiMedx Group adopts a prudent financial strategy, indicating a balanced approach to debt management.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: MiMedx Group's P/E ratio of 22.0 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 2.51, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): MiMedx Group's EV/EBITDA ratio of 12.71 exceeds industry averages, indicating a premium valuation in the market
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Understanding the Significance of Insider Transactions</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Understanding Crucial Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001376339">Check Out The Full List Of MiMedx Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Noteworthy Insider Activity: William A Hawkins Invests $185K In MiMedx Group Stock

A new SEC filing reveals that James L Bierman, Board Member at MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>), made a notable insider purchase on June 23,.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001376339/000137633925000070//Archives/edgar/data/1376339/000137633925000070/0001376339-25-000070-index.htm">U.S. Securities and Exchange Commission</a> on Monday unveiled that Bierman made a notable purchase of 28,609 shares of MiMedx Group, valuing at $185,100.
Monitoring the market, MiMedx Group's shares down by 0.0% at $5.94 during Tuesday's morning.
<h3>About MiMedx Group</h3>
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin &amp; bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
<h3>MiMedx Group: A Financial Overview</h3>
Positive Revenue Trend: Examining MiMedx Group's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.13% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 81.23%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): MiMedx Group's EPS reflects a decline, falling below the industry average with a current EPS of 0.05.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.09, MiMedx Group adopts a prudent financial strategy, indicating a balanced approach to debt management.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 22.0 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 2.51 is lower than the industry average, implying a discounted valuation for MiMedx Group's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 12.71, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
When it comes to transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S indicates a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001376339">Check Out The Full List Of MiMedx Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Positive Signal: James L Bierman Shows Faith, Buying $185K In MiMedx Group Stock

In a recent SEC filing, it was revealed that William F. Hulse as attorney-in-factM. Kathleen Behrens Wilsey, Board Member at MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>), made a noteworthy insider purchase on June 23,.
What Happened: Wilsey's recent move, as outlined in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001376339/000137633925000072//Archives/edgar/data/1376339/000137633925000072/0001376339-25-000072-index.htm">U.S. Securities and Exchange Commission</a> on Monday, involves purchasing 28,609 shares of MiMedx Group. The total transaction value is $185,100.
Tracking the Tuesday's morning session, MiMedx Group shares are trading at $5.94, showing a down of 0.0%.
<h3>Discovering MiMedx Group: A Closer Look</h3>
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin &amp; bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
<h3>MiMedx Group's Financial Performance</h3>
Revenue Growth: Over the 3 months period, MiMedx Group showcased positive performance, achieving a revenue growth rate of 4.13% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 81.23%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, MiMedx Group exhibits below-average bottom-line performance with a current EPS of 0.05.
</li>
</ul>
Debt Management: MiMedx Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.09.
Navigating Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 22.0 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 2.51 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A high EV/EBITDA ratio of 12.71 reflects market recognition of MiMedx Group's value, positioning it as more highly valued compared to industry peers.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
Insider transactions should be considered alongside other factors when making investment decisions, as they can offer important insights.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001376339">Check Out The Full List Of MiMedx Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

William F. Hulse as attorney-in-factM. Kathleen Behrens Wilsey's Recent Buy: Acquires $185K In MiMedx Group Stock

<a href="https://www.ft.com/content/3d336a84-ac59-45ee-b857-8a01fc7cd806" title="https://www.ft.com/content/3d336a84-ac59-45ee-b857-8a01fc7cd806">https://www.ft.com/content/3d336a84-ac59-45ee-b857-8a01fc7cd806</a>

Macro Economic Events

Politics

Global

Economics

General

'EU Readies Retaliatory Tariffs To Secure Better Trade Deal With Trump; German Chancellor Backs More Muscular Approach Ahead Of July Talks Deadline' - Financial Times

A significant insider buy by Todd Newton, Board Member at MiMedx Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDXG#NASDAQ">MDXG</a>), was executed on June 23, and reported in the recent SEC filing.
What Happened: In a Form 4 filing on Monday with the <a href="https://www.sec.gov/Archives/edgar/data/0001376339/000137633925000075//Archives/edgar/data/1376339/000137633925000075/0001376339-25-000075-index.htm">U.S. Securities and Exchange Commission</a>, it was disclosed that Newton bought 28,609 shares of MiMedx Group, amounting to a total of $185,100.
The latest market snapshot at Tuesday morning reveals MiMedx Group shares down by 0.0%, trading at $5.94.
<h3>Get to Know MiMedx Group Better</h3>
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin &amp; bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
<h3>Breaking Down MiMedx Group's Financial Performance</h3>
Positive Revenue Trend: Examining MiMedx Group's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.13% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: With a low gross margin of 81.23%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): MiMedx Group's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.05.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.09, MiMedx Group adopts a prudent financial strategy, indicating a balanced approach to debt management.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 22.0 is lower than the industry average, implying a discounted valuation for MiMedx Group's stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 2.51 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 12.71, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Impact of Insider Transactions on Investments</h3>
Insightful as they may be, insider transactions should be considered alongside a thorough examination of other investment criteria.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>A Deep Dive into Insider Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001376339">Check Out The Full List Of MiMedx Group's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Bullish Move: Todd Newton Shows Confidence, Acquires $185K In MiMedx Group Stock

<a href="https://www.youtube.com/watch?v=iQAnZXa1Kpg">https://www.youtube.com/watch?v=iQAnZXa1Kpg</a>

Macro Notification

Fed Chair Powell Says Leverage Ratio Reform Should Encourage More Mediation By Banks In Treasuries; Says Look Forward To Putting Proposal Out For Comment

A substantial insider sell was reported on June 24, by Ingrid Estrada, SVP at Keysight Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>), based on the recent SEC filing.
What Happened: Estrada's decision to sell 10,000 shares of Keysight Techs was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001601046/000160104625000075//Archives/edgar/data/1601046/000160104625000075/0001601046-25-000075-index.htm">U.S. Securities and Exchange Commission</a> on Tuesday. The total value of the sale is $1,589,682.
Keysight Techs's shares are actively trading at $163.86, experiencing a up of 1.73% during Tuesday's morning session.
<h3>All You Need to Know About Keysight Techs</h3>
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.
<h3>Key Indicators: Keysight Techs's Financial Health</h3>
Revenue Growth: Keysight Techs displayed positive results in 3 months. As of 30 April, 2025, the company achieved a solid revenue growth rate of approximately 7.4%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 62.33%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Keysight Techs's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 1.49.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.5.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 37.81 is lower than the industry average, implying a discounted valuation for Keysight Techs's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 5.5, Keysight Techs's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): A high EV/EBITDA ratio of 20.58 reflects market recognition of Keysight Techs's value, positioning it as more highly valued compared to industry peers.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001601046">Check Out The Full List Of Keysight Techs's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

KEYS

Insider Unloading: Ingrid Estrada Sells $1.59M Worth Of Keysight Techs Shares

Disclosed in a recent SEC filing, Alan King, Group President at Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>), made a strategic move by acquiring company stock options on June 23,.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001175454/000095017025089033//Archives/edgar/data/1175454/000095017025089033/0000950170-25-089033-index.htm">U.S. Securities and Exchange Commission</a> on Monday showed that King, Group President at Corpay, a company in the Financials sector, acquired stock options for 15,000 shares of CPAY. The options allow King to buy the company's stock at $280.97 per share.
The Tuesday morning market activity shows Corpay shares up by 1.87%, trading at $327.87. This implies a total value of $703,424 for King's 15,000 shares.
<h3>Discovering Corpay: A Closer Look</h3>
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
<h3>Corpay: Delving into Financials</h3>
Revenue Growth: Corpay's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 7.53%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: With a high gross margin of 77.94%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): Corpay's EPS outshines the industry average, indicating a strong bottom-line trend with a current EPS of 3.46.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 2.37, Corpay faces challenges in effectively managing its debt levels, indicating potential financial strain.
Assessing Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 22.59 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 5.68, Corpay's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Corpay's EV/EBITDA ratio at 13.61 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001175454">Check Out The Full List Of Corpay's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CPAY

A Noteworthy Decision By Alan King As Acquires $703K In Corpay Stock Options

A substantial insider activity was disclosed on June 24, as Hacker, Chief Tech Officer at Duolingo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DUOL#NASDAQ">DUOL</a>), reported the exercise of a large sell of company stock options.
What Happened: In an insider options sale disclosed in a Form 4 filing on Tuesday with the <a href="https://www.sec.gov/Archives/edgar/data/0001562088/000156208825000153//Archives/edgar/data/1562088/000156208825000153/0001562088-25-000153-index.htm">U.S. Securities and Exchange Commission</a>, Hacker, Chief Tech Officer at Duolingo, exercised stock options for 10,000 shares of DUOL. The transaction value amounted to $4,021,050.
Duolingo shares are currently trading down by 1.86%, with a current price of $440.19 as of Tuesday morning. This brings the total value of Hacker's 10,000 shares to $4,021,050.
<h3>About Duolingo</h3>
Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.
<h3>Duolingo's Financial Performance</h3>
Revenue Growth: Duolingo's remarkable performance in 3 months is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 37.71%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 71.12%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Duolingo's EPS is below the industry average. The company faced challenges with a current EPS of 0.78. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.06.
Valuation Metrics: A Closer Look
<ul>
<li>
Price to Earnings (P/E) Ratio: With a higher-than-average P/E ratio of 220.96, Duolingo's stock is perceived as being overvalued in the market.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 26.2 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 236.77, the company's EV/EBITDA ratio outperforms industry norms, reflecting positive market perception. This positioning indicates optimistic expectations for the company's future performance.
</li>
</ul>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001562088">Check Out The Full List Of Duolingo's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DUOL

Options Movement At Duolingo: Severin Hacker Exercises Worth $4.02M

Disclosed in a recent SEC filing on June 24, Cosset, Executive Vice President at Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>), made a noteworthy transaction involving the exercise of company stock options.
What Happened: Disclosed in a Form 4 filing on Tuesday with the <a href="https://www.sec.gov/Archives/edgar/data/0000056873/000095017025089236//Archives/edgar/data/56873/000095017025089236/0000950170-25-089236-index.htm">U.S. Securities and Exchange Commission</a>, Cosset, Executive Vice President at Kroger, executed a strategic derivative sale. This involved exercising stock options for 71,224 shares of KR, resulting in a transaction value of $3,116,406.
Kroger shares are trading, exhibiting down of 1.52% and priced at $72.88 during Tuesday's morning. This values Cosset's 71,224 shares at $3,116,406.
<h3>All You Need to Know About Kroger</h3>
Kroger is one of the largest grocery retailers in the United States with more than 2,700 stores across a portfolio of over 20 supermarket banners. The company boasts an ingrained presence in US communities, citing that it is a top-two grocer in most of its major market areas. Over one fourth of Kroger's roughly $110 billion in nonperishable and fresh food sales (about 75% of revenue) stems from its private-label portfolio, of which the company manufactures about 30% of units via its own food production plants. The company also operates fuel stations and pharmacies at 60% and 80% of its locations, respectively.
<h3>Kroger's Financial Performance</h3>
Revenue Growth: Kroger's revenue growth over a period of 3 months has been noteworthy. As of 30 April, 2025, the company achieved a revenue growth rate of approximately 31.51%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Consumer Staples sector, the company excelled with a growth rate higher than the average among peers.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 23.42%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Kroger's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.3.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 2.83, Kroger faces challenges in effectively managing its debt levels, indicating potential financial strain.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: Kroger's P/E ratio of 20.16 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: The P/S ratio of 0.35 is lower than the industry average, implying a discounted valuation for Kroger's stock in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio of 8.86 trails industry averages, indicating a potential disparity in market valuation that could be advantageous for investors.
</li>
</ul>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Key in Investment Decisions</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In the context of legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as outlined by Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are obligated to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Despite insider sells not always signaling a bearish sentiment, they can be driven by various factors.
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000056873">Check Out The Full List Of Kroger's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Decision: Yael Cosset Exercises Options At Kroger For $3.12M

In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a comprehensive industry comparison, evaluating Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) against its key competitors in the Broadline Retail industry. By analyzing important financial metrics, market position, and growth prospects, we aim to provide valuable insights for investors and shed light on company's performance within the industry.
<h3>Amazon.com Background</h3>
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 75% of total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (15%), advertising services (5% to 10%), and other the remainder. International segments constitute 25% to 30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amazon.com Inc</td>
<td>33.95</td>
<td>7.24</td>
<td>3.45</td>
<td>5.79%</td>
<td>$36.48</td>
<td>$78.69</td>
<td>8.62%</td>
</tr>
<tr>
<td>Alibaba Group Holding Ltd</td>
<td>15.17</td>
<td>1.92</td>
<td>1.97</td>
<td>1.23%</td>
<td>$59.0</td>
<td>$117.63</td>
<td>-15.6%</td>
</tr>
<tr>
<td>PDD Holdings Inc</td>
<td>10.94</td>
<td>3.16</td>
<td>2.69</td>
<td>4.59%</td>
<td>$16.09</td>
<td>$54.73</td>
<td>10.21%</td>
</tr>
<tr>
<td>MercadoLibre Inc</td>
<td>60.34</td>
<td>24.85</td>
<td>5.56</td>
<td>10.56%</td>
<td>$0.92</td>
<td>$2.77</td>
<td>36.97%</td>
</tr>
<tr>
<td>Coupang Inc</td>
<td>202.71</td>
<td>11.79</td>
<td>1.67</td>
<td>2.53%</td>
<td>$0.36</td>
<td>$2.32</td>
<td>11.16%</td>
</tr>
<tr>
<td>JD.com Inc</td>
<td>7.70</td>
<td>1.40</td>
<td>0.29</td>
<td>4.6%</td>
<td>$14.27</td>
<td>$47.85</td>
<td>15.78%</td>
</tr>
<tr>
<td>eBay Inc</td>
<td>18.48</td>
<td>7.16</td>
<td>3.65</td>
<td>9.95%</td>
<td>$0.77</td>
<td>$1.86</td>
<td>1.13%</td>
</tr>
<tr>
<td>Ollie's Bargain Outlet Holdings Inc</td>
<td>39.76</td>
<td>4.58</td>
<td>3.41</td>
<td>2.78%</td>
<td>$0.07</td>
<td>$0.24</td>
<td>13.35%</td>
</tr>
<tr>
<td>Vipshop Holdings Ltd</td>
<td>7.57</td>
<td>1.35</td>
<td>0.52</td>
<td>4.85%</td>
<td>$2.45</td>
<td>$6.08</td>
<td>-4.98%</td>
</tr>
<tr>
<td>Dillard's Inc</td>
<td>11.17</td>
<td>3.39</td>
<td>0.98</td>
<td>8.97%</td>
<td>$0.26</td>
<td>$0.69</td>
<td>-1.64%</td>
</tr>
<tr>
<td>MINISO Group Holding Ltd</td>
<td>15.78</td>
<td>3.58</td>
<td>2.18</td>
<td>3.98%</td>
<td>$0.65</td>
<td>$1.96</td>
<td>18.89%</td>
</tr>
<tr>
<td>Macy's Inc</td>
<td>5.37</td>
<td>0.65</td>
<td>0.13</td>
<td>0.84%</td>
<td>$0.31</td>
<td>$2.0</td>
<td>-4.14%</td>
</tr>
<tr>
<td>Savers Value Village Inc</td>
<td>75.14</td>
<td>3.95</td>
<td>1.12</td>
<td>-1.13%</td>
<td>$0.03</td>
<td>$0.2</td>
<td>4.51%</td>
</tr>
<tr>
<td>Kohl's Corp</td>
<td>7.43</td>
<td>0.24</td>
<td>0.06</td>
<td>-0.4%</td>
<td>$0.23</td>
<td>$1.4</td>
<td>-4.41%</td>
</tr>
<tr>
<td>Hour Loop Inc</td>
<td>142</td>
<td>8.58</td>
<td>0.36</td>
<td>11.93%</td>
<td>$0.0</td>
<td>$0.01</td>
<td>4.68%</td>
</tr>
<tr>
<td>Average</td>
<td>44.25</td>
<td>5.47</td>
<td>1.76</td>
<td>4.66%</td>
<td>$6.82</td>
<td>$17.12</td>
<td>6.14%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>By carefully studying Amazon.com, we can deduce the following trends: 
<ul>
<li>
The Price to Earnings ratio of 33.95 is 0.77x lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
With a Price to Book ratio of 7.24, which is 1.32x the industry average, Amazon.com might be considered overvalued in terms of its book value, as it is trading at a higher multiple compared to its industry peers.
</li>
<li>
The stock's relatively high Price to Sales ratio of 3.45, surpassing the industry average by 1.96x, may indicate an aspect of overvaluation in terms of sales performance.
</li>
<li>
With a Return on Equity (ROE) of 5.79% that is 1.13% above the industry average, it appears that the company exhibits efficient use of equity to generate profits.
</li>
<li>
Compared to its industry, the company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $36.48 Billion, which is 5.35x above the industry average, indicating stronger profitability and robust cash flow generation.
</li>
<li>
The company has higher gross profit of $78.69 Billion, which indicates 4.6x above the industry average, indicating stronger profitability and higher earnings from its core operations.
</li>
<li>
The company is experiencing remarkable revenue growth, with a rate of 8.62%, outperforming the industry average of 6.14%.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750777291_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is a key indicator of a company's financial health and its reliance on debt financing.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In terms of the Debt-to-Equity ratio, Amazon.com stands in comparison with its top 4 peers, leading to the following comparisons:
<ul>
<li>
Amazon.com is in a relatively stronger financial position compared to its top 4 peers, as evidenced by its lower debt-to-equity ratio of 0.44.
</li>
<li>
This implies that the company relies less on debt financing and has a more favorable balance between debt and equity.
</li>
</ul>
<h3>Key Takeaways</h3>
For Amazon.com, the PE ratio is low compared to its peers in the Broadline Retail industry, indicating potential undervaluation. The high PB and PS ratios suggest that the market values Amazon.com's assets and sales more than its earnings. In terms of ROE, EBITDA, gross profit, and revenue growth, Amazon.com outperforms its industry peers, reflecting strong profitability and growth potential.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Markets

AMZN

Inquiry Into Amazon.com's Competitor Dynamics In Broadline Retail Industry

In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry comparison, evaluating Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) in relation to its major competitors in the Technology Hardware, Storage &amp; Peripherals industry. By closely examining crucial financial metrics, market position, and growth prospects, we aim to offer valuable insights for investors and shed light on company's performance within the industry.
<h3>Apple Background</h3>
Apple is among the largest companies in the world, with a broad portfolio of hardware and software products targeted at consumers and businesses. Apple's iPhone makes up a majority of the firm sales, and Apple's other products like Mac, iPad, and Watch are designed around the iPhone as the focal point of an expansive software ecosystem. Apple has progressively worked to add new applications, like streaming video, subscription bundles, and augmented reality. The firm designs its own software and semiconductors while working with subcontractors like Foxconn and TSMC to build its products and chips. Slightly less than half of Apple's sales come directly through its flagship stores, with a majority of sales coming indirectly through partnerships and distribution.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Apple Inc</td>
<td>31.39</td>
<td>45.06</td>
<td>7.65</td>
<td>37.11%</td>
<td>$32.25</td>
<td>$44.87</td>
<td>5.08%</td>
</tr>
<tr>
<td>Super Micro Computer Inc</td>
<td>22.22</td>
<td>3.83</td>
<td>1.19</td>
<td>1.72%</td>
<td>$0.14</td>
<td>$0.44</td>
<td>19.48%</td>
</tr>
<tr>
<td>Hewlett Packard Enterprise Co</td>
<td>17.12</td>
<td>0.98</td>
<td>0.75</td>
<td>-4.4%</td>
<td>$0.87</td>
<td>$2.17</td>
<td>5.87%</td>
</tr>
<tr>
<td>NetApp Inc</td>
<td>18.39</td>
<td>20.09</td>
<td>3.32</td>
<td>33.42%</td>
<td>$0.43</td>
<td>$1.19</td>
<td>3.84%</td>
</tr>
<tr>
<td>Western Digital Corp</td>
<td>20.68</td>
<td>4.07</td>
<td>1.36</td>
<td>5.86%</td>
<td>$0.28</td>
<td>$0.91</td>
<td>30.94%</td>
</tr>
<tr>
<td>Pure Storage Inc</td>
<td>140.13</td>
<td>13.99</td>
<td>5.63</td>
<td>-1.1%</td>
<td>$0.04</td>
<td>$0.54</td>
<td>12.26%</td>
</tr>
<tr>
<td>Logitech International SA</td>
<td>20.81</td>
<td>5.97</td>
<td>2.88</td>
<td>6.81%</td>
<td>$0.14</td>
<td>$0.44</td>
<td>-0.11%</td>
</tr>
<tr>
<td>Eastman Kodak Co</td>
<td>11.92</td>
<td>0.82</td>
<td>0.49</td>
<td>-1.66%</td>
<td>$0.02</td>
<td>$0.05</td>
<td>-0.8%</td>
</tr>
<tr>
<td>Turtle Beach Corp</td>
<td>18.08</td>
<td>2.23</td>
<td>0.74</td>
<td>-0.55%</td>
<td>$0.0</td>
<td>$0.02</td>
<td>14.42%</td>
</tr>
<tr>
<td>Average</td>
<td>33.67</td>
<td>6.5</td>
<td>2.04</td>
<td>5.01%</td>
<td>$0.24</td>
<td>$0.72</td>
<td>10.74%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>After examining Apple, the following trends can be inferred: 
<ul>
<li>
At 31.39, the stock's Price to Earnings ratio is 0.93x less than the industry average, suggesting favorable growth potential.
</li>
<li>
With a Price to Book ratio of 45.06, which is 6.93x the industry average, Apple might be considered overvalued in terms of its book value, as it is trading at a higher multiple compared to its industry peers.
</li>
<li>
The stock's relatively high Price to Sales ratio of 7.65, surpassing the industry average by 3.75x, may indicate an aspect of overvaluation in terms of sales performance.
</li>
<li>
With a Return on Equity (ROE) of 37.11% that is 32.1% above the industry average, it appears that the company exhibits efficient use of equity to generate profits.
</li>
<li>
The company exhibits higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $32.25 Billion, which is 134.38x above the industry average, implying stronger profitability and robust cash flow generation.
</li>
<li>
Compared to its industry, the company has higher gross profit of $44.87 Billion, which indicates 62.32x above the industry average, indicating stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of 5.08% is significantly lower compared to the industry average of 10.74%. This indicates a potential fall in the company's sales performance.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750777281_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is an important measure to assess the financial structure and risk profile of a company.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In light of the Debt-to-Equity ratio, a comparison between Apple and its top 4 peers reveals the following information:
<ul>
<li>
In the context of the debt-to-equity ratio, Apple holds a middle position among its top 4 peers.
</li>
<li>
This indicates a moderate level of debt relative to its equity with a debt-to-equity ratio of 1.47, which implies a relatively balanced financial structure with a reasonable debt-equity mix.
</li>
</ul>
<h3>Key Takeaways</h3>
For Apple in the Technology Hardware, Storage &amp; Peripherals industry, the PE ratio is low compared to peers, indicating potential undervaluation. The PB and PS ratios are high, suggesting overvaluation relative to industry standards. In terms of ROE, EBITDA, gross profit, and revenue growth, Apple demonstrates strong performance compared to its industry peers, reflecting favorable financial health and operational efficiency.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

Investigating Apple's Standing In Technology Hardware, Storage &amp; Peripherals Industry Compared To Competitors

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry observers. In this article, we will conduct an extensive industry comparison, evaluating Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) in relation to its major competitors in the Interactive Media &amp; Services industry. Through a detailed examination of key financial metrics, market standing, and growth prospects, our objective is to provide valuable insights and illuminate company's performance in the industry.
<h3>Meta Platforms Background</h3>
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
<table>
<thead>
<tr>
<th>Company</th>
<th>P/E</th>
<th>P/B</th>
<th>P/S</th>
<th>ROE</th>
<th>EBITDA (in billions)</th>
<th>Gross Profit (in billions)</th>
<th>Revenue Growth</th>
</tr>
</thead>
<tbody>
<tr>
<td>Meta Platforms Inc</td>
<td>27.31</td>
<td>9.49</td>
<td>10.68</td>
<td>9.05%</td>
<td>$22.52</td>
<td>$34.74</td>
<td>16.07%</td>
</tr>
<tr>
<td>Alphabet Inc</td>
<td>18.44</td>
<td>5.81</td>
<td>5.63</td>
<td>10.3%</td>
<td>$46.31</td>
<td>$53.87</td>
<td>12.04%</td>
</tr>
<tr>
<td>Baidu Inc</td>
<td>8.34</td>
<td>0.77</td>
<td>1.57</td>
<td>2.89%</td>
<td>$9.8</td>
<td>$14.96</td>
<td>2.98%</td>
</tr>
<tr>
<td>Reddit Inc</td>
<td>26.88</td>
<td>11.16</td>
<td>16.49</td>
<td>1.2%</td>
<td>$0.01</td>
<td>$0.36</td>
<td>61.49%</td>
</tr>
<tr>
<td>Pinterest Inc</td>
<td>12.50</td>
<td>4.91</td>
<td>6.34</td>
<td>0.19%</td>
<td>$-0.03</td>
<td>$0.66</td>
<td>15.54%</td>
</tr>
<tr>
<td>Kanzhun Ltd</td>
<td>31</td>
<td>3.56</td>
<td>7.60</td>
<td>3.38%</td>
<td>$0.44</td>
<td>$1.61</td>
<td>12.88%</td>
</tr>
<tr>
<td>Trump Media &amp; Technology Group Corp</td>
<td>16.12</td>
<td>5.56</td>
<td>985.25</td>
<td>-3.51%</td>
<td>$-0.03</td>
<td>$0.0</td>
<td>6.58%</td>
</tr>
<tr>
<td>CarGurus Inc</td>
<td>87.92</td>
<td>8</td>
<td>3.79</td>
<td>8.27%</td>
<td>$0.05</td>
<td>$0.2</td>
<td>4.34%</td>
</tr>
<tr>
<td>ZoomInfo Technologies Inc</td>
<td>81</td>
<td>1.94</td>
<td>2.83</td>
<td>1.6%</td>
<td>$0.07</td>
<td>$0.26</td>
<td>-1.42%</td>
</tr>
<tr>
<td>Weibo Corp</td>
<td>6.72</td>
<td>0.66</td>
<td>1.41</td>
<td>3.09%</td>
<td>$0.11</td>
<td>$0.31</td>
<td>0.34%</td>
</tr>
<tr>
<td>Yelp Inc</td>
<td>16.75</td>
<td>3</td>
<td>1.65</td>
<td>3.31%</td>
<td>$0.05</td>
<td>$0.32</td>
<td>7.75%</td>
</tr>
<tr>
<td>Tripadvisor Inc</td>
<td>33.49</td>
<td>2.40</td>
<td>1.03</td>
<td>-1.39%</td>
<td>$0.01</td>
<td>$0.37</td>
<td>0.76%</td>
</tr>
<tr>
<td>Hello Group Inc</td>
<td>7.92</td>
<td>0.88</td>
<td>1.04</td>
<td>3.21%</td>
<td>$0.44</td>
<td>$0.95</td>
<td>-1.55%</td>
</tr>
<tr>
<td>Ziff Davis Inc</td>
<td>18.06</td>
<td>0.73</td>
<td>0.98</td>
<td>1.37%</td>
<td>$0.09</td>
<td>$0.28</td>
<td>4.5%</td>
</tr>
<tr>
<td>Taboola.com Ltd</td>
<td>90.75</td>
<td>1.16</td>
<td>0.70</td>
<td>-0.85%</td>
<td>$0.01</td>
<td>$0.12</td>
<td>3.26%</td>
</tr>
<tr>
<td>Vtex</td>
<td>90.28</td>
<td>4.82</td>
<td>5.30</td>
<td>0.34%</td>
<td>$0.0</td>
<td>$0.04</td>
<td>2.9%</td>
</tr>
<tr>
<td>Average</td>
<td>36.41</td>
<td>3.69</td>
<td>69.44</td>
<td>2.23%</td>
<td>$3.82</td>
<td>$4.95</td>
<td>8.83%</td>
</tr>
</tbody>
</table>
<style>
 table {
 width: 100%;
 border-collapse: collapse;
 font-family: Arial, sans-serif;
 font-size: 14px;
 }

 th, td {
 padding: 8px;
 text-align: left;
 }

 th {
 background-color: #293a5a;
 color: #fff;
 text-align: left;
 }

 tr:nth-child(even) {
 background-color: #f2f4f8;
 }

 tr:hover {
 background-color: #e1e4ea;
 }

 td:nth-child(3), td:nth-child(5) {
 text-align: left;
 }

 .dividend-amount {
 font-weight: bold;
 color: #0d6efd;
 }

 .dividend-frequency {
 font-size: 12px;
 color: #6c757d;
 }
 </style>When analyzing Meta Platforms, the following trends become evident: 
<ul>
<li>
At 27.31, the stock's Price to Earnings ratio is 0.75x less than the industry average, suggesting favorable growth potential.
</li>
<li>
The elevated Price to Book ratio of 9.49 relative to the industry average by 2.57x suggests company might be overvalued based on its book value.
</li>
<li>
The Price to Sales ratio is 10.68, which is 0.15x the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
The company has a higher Return on Equity (ROE) of 9.05%, which is 6.82% above the industry average. This suggests efficient use of equity to generate profits and demonstrates profitability and growth potential.
</li>
<li>
The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $22.52 Billion is 5.9x above the industry average, highlighting stronger profitability and robust cash flow generation.
</li>
<li>
The gross profit of $34.74 Billion is 7.02x above that of its industry, highlighting stronger profitability and higher earnings from its core operations.
</li>
<li>
The company's revenue growth of 16.07% exceeds the industry average of 8.83%, indicating strong sales performance and market outperformance.
</li>
</ul>
<h3>Debt To Equity Ratio</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750777273_0.png" alt="debt to equity" />
The debt-to-equity (D/E) ratio is a financial metric that helps determine the level of financial risk associated with a company's capital structure.
Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.
In light of the Debt-to-Equity ratio, a comparison between Meta Platforms and its top 4 peers reveals the following information:
<ul>
<li>
Compared to its top 4 peers, Meta Platforms has a stronger financial position indicated by its lower debt-to-equity ratio of 0.27.
</li>
<li>
This suggests that the company relies less on debt financing and has a more favorable balance between debt and equity, which can be seen as a positive attribute by investors.
</li>
</ul>
<h3>Key Takeaways</h3>
For Meta Platforms, the low PE ratio suggests potential undervaluation compared to peers in the Interactive Media &amp; Services industry. The high PB ratio indicates a premium placed on the company's assets. A low PS ratio implies a favorable valuation based on revenue. The high ROE, EBITDA, gross profit, and revenue growth signify strong operational performance and growth prospects relative to industry competitors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comparative Study: Meta Platforms And Industry Competitors In Interactive Media &amp; Services Industry

Press Releases

Yum China named as a "Top Employer" in China by Top Employers Institute for seventh consecutive year, achieving Top 2 national ranking

Dividends

Yum China Announces Disclosure under Hong Kong Stock Exchange Rules in Relation to a Possible Quarterly Dividend

Yum China Reports Fourth Quarter Results and Increases Dividend by 50%

Yum China Appoints Adrian Ding as Chief Financial Officer

2024 Sustainability Report Showcases Yum China's Consistent Commitment to ESG

Yum China to Report First Quarter 2025 Financial Results

Yum China Reports First Quarter Results

Contracts

Yum China Announces US$510 Million Share Repurchase Agreements for Second Half of 2025 as Part of Broader Capital Return Plan

Yum China launches AI assistant for store managers, a groundbreaking advance in its tech-driven growth strategy

Arcos Dorados Holdings Inc. Class A Shares

Arcos Dorados Holdings

Aramark

BJ's Restaurants

Dutch Bros

The Cheesecake Factory Incorporated - Common Stock

Cheesecake Factory

Cava Group

Cracker Barrel Old Country Store, Inc. - Common Stock

Cracker Barrel Old

Chagee Holdings Limited - American Depositary Shares, each representing 1 Class A ordinary share

Chagee Holdings

Chipotle Mexican Grill, Inc. Common Stock

Chipotle Mexican Grill

DoorDash

Domino's Pizza

Darden Restaurants

Brinker International

SUPER HI INTERNATIONAL HOLDING LTD. - American Depositary Shares

Super Hi International

Kura Sushi USA, Inc. - Class A Common Stock

Kura Sushi USA

McDonald's

Papa John's International, Inc. - Common Stock

Papa John's International

Restaurant Brands International Inc. Common Shares

Restaurant Brands Intl

Starbucks

Sweetgreen

Shake Shack

Texas Roadhouse

Wendy's

Wingstop

Yum Brands

JP Morgan

Macquarie

HSBC

Deutsche Bank

지난주 성과가 가장 부진했던 대형주는 다음과 같다.
<ol>
<li>유나이티드헬스 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) 주가는 회사가 예상보다 저조한 1분기 실적을 발표하고 2025회계연도 조정 <a href="https://www.benzinga.com//node/44860240" target="_blank" rel="noreferrer noopener">EPS 가이드를 하향 조정한 후 23.60% 하락했다</a>.</li>
<li>글로벌 페이먼츠(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) 주가는 회사가 <a href="https://www.benzinga.com//node/44862867" target="_blank" rel="noreferrer noopener">월드페이(Worldpay)의 지분을 66억 달러에 인수했다고 발표한 후 16.55% 하락했다</a>.</li>
<li>앱러빈(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>)의 주가는 골드만 삭스(Goldman Sachs)의 애널리스트 에릭 셰리단이 <a href="https://www.benzinga.com/quote/app/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 500달러에서 335달러로 하향 조정한 후 9.71% 하락했다</a>.</li>
<li>휴매나(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) 주가는 유나이티드헬스 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)이 예상보다 안 좋은 <a href="https://www.benzinga.com//node/44860240" target="_blank" rel="noreferrer noopener">1분기 실적을 발표한 후 8.88% 하락했다</a>.</li>
<li>다비타(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>)의 주가는 지난 주 8.69% 하락했다.</li>
<li>메타 플랫폼스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)의 주가는 <a href="https://www.benzinga.com//node/44821791" target="_blank" rel="noreferrer noopener">FTC 반독점 재판 중에 8.20% 하락했다</a>. 여러 애널리스트가 <a href="https://www.benzinga.com/quote/meta/analyst-ratings" target="_blank" rel="noreferrer noopener">주가 예측을 하향 조정했다</a>.</li>
<li>염 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)의 주가는 7.70% 급락했다.</li>
<li>코어위브(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>)의 주가는 7.37% 하락했다.</li>
<li>벌링턴 스토어스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>)의 주가는 연준 의장 파월이 경제 클럽에서 발언한 후 전반적인 시장 약세 속에서 6.97% 하락했다.</li>
<li>슈퍼 마이크로 컴퓨터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>)의 주가는 JP 모건 애널리스트 새믹 채터지가 <a href="https://www.benzinga.com/quote/smci/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 45달러에서 39달러로 하향 조정한 후 6.46% 하락했다</a>.</li>
<li>글로벌파운드리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) 주가는 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)에서 미국 정부가 최근에 중국에 칩을 수출하기 위해 <a href="https://www.benzinga.com//node/44856114" target="_blank" rel="noreferrer noopener">면허가 필요하다고 통보했다고 발표한 후 6.24% 하락했다</a>.</li>
</ol>
사진 출처: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

4월 7일부터 11일까지 지난주 최악의 실적을 기록한 대형주는 다음과 같다.
<ol>
<li>PDD홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) 주가는 13.16% 급락했다. 도널드 트럼프 대통령이 외국 이커머스 회사들이 <a href="https://www.benzinga.com//node/44714336" target="_blank" rel="noreferrer noopener">(800달러 이하의) 저렴한 패키지를 미국으로 무관세로 배송할 수 있게 해주던 소액 면세(de minimis) 기준을 폐지</a>했다.</li>
<li>페트롤레오 브라질레이로(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PBR#NYSE">PBR</a>) 주가는 11.96% 하락했다. 트럼프 대통령의 관세 유예 발표 이후 주식들이 급등한 뒤 조정을 받았다.</li>
<li>카맥스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) 주가는 9.72% 급락했다. 회사가 4분기<a href="https://www.benzinga.com//node/44733776" target="_blank" rel="noreferrer noopener"> 실적을 발표했지만 EPS 추정치를 밑돌았다.</a> 여러 애널리스트들이<a href="https://www.benzinga.com/quote/kmx/analyst-ratings" target="_blank" rel="noreferrer noopener"> 주가 전망치를 하향 조정</a>했다.</li>
<li>앱티브(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) 주가는 9.58% 하락했다. UBS 애널리스트 조셉 스팍이 매수에서 중립으로 등급을 하향 조정하고 <a href="https://www.benzinga.com/quote/aptv/analyst-ratings" target="_blank" rel="noreferrer noopener">목표주가를 91달러에서 58달러</a>로 낮췄다.</li>
<li>스텔란티스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) 주가는 8.74% 하락했다. 회사가 1분기 동안 출하량이 전년 대비 9% 감소하여 약<a href="https://www.benzinga.com//node/44763932" target="_blank" rel="noreferrer noopener"> 120만 대에 이르렀다고 발표</a>했다.</li>
<li>코어위브(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWV#NASDAQ">CRWV</a>) 주가는 8.51% 급락했다.</li>
<li>브리스톨 마이어스 스퀴브(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) 주가는 8.30% 하락했다. 트럼프 대통령이 자신의 집무실에서 기자들과의 대화 중<a href="https://www.benzinga.com//node/44756157" target="_blank" rel="noreferrer noopener"> 제약사들이 관세에 직면할 것이라고 확인</a>했다.</li>
<li>질로우 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) 주가는 8.09% 하락했다. 이는 미국-중국 무역 긴장 속에서 전체 시장이 반전되었기 때문이다. 30년 모기지 금리의 변동성도 주택 수요에 영향을 미칠 수 있다.</li>
<li>알리바바 그룹 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) 주가는 7.56% 하락했다. 미국과 중국 간의 무역 긴장이 격화되면서 이커머스<a href="https://www.benzinga.com//node/44704439" target="_blank" rel="noreferrer noopener"> 거대 기업의 국제 비즈니스 모델을 위협</a>하고 있다.</li>
<li>염 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) 주가는 지난주 7.37% 하락했다. 이는 미국-중국 무역 발표와 전체 시장 약세가 영향을 미쳤다.</li>
</ol>
사진 제공: Paulm1993 via Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 수익률을 높이세요.
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

이들 9개 대형주는 지난주 최악의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 카바나(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>)의 주가는 20.93% 급락했다. 공매도 업체인 힌덴버그 리서치의 비판적인 보고서는 <a href="https://www.benzinga.com//node/42784518" target="_blank" rel="noreferrer noopener">Carvana의 회복을 &#8220;신기루&#8221;</a>로 묘사하면서 약세 정서를 강화했다.
2. 소파이 테크놀로지스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>)의 주식은 키프, 브루옛 &amp; 우즈(Keefe, Bruyette and Woods)가 <a href="https://www.benzinga.com/quote/SOfi/analyst-ratings" target="_blank" rel="noreferrer noopener">시장 수행에서 언더퍼폼으로 하향 조정</a>한 후 10.60% 하락했다.
3. 얌 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)의 주식은 10.40% 하락했다.
4. 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)의 주식은 회사가 4분기 <a href="https://www.benzinga.com//node/42766117" target="_blank" rel="noreferrer noopener">생산 및 인도 수치</a>를 발표한 후 9.62% 급락했다. 애널리스트들은 주식에 대한 <a href="https://www.benzinga.com//node/42786667" target="_blank" rel="noreferrer noopener">가격 예측</a>을 수정했다.
5. 킨세일 캐피털 그룹(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNSL#NYSE">KNSL</a>)의 주식은 JP 모건이 주식의 목표 가격을 <a href="https://www.benzinga.com/quote/knsl/analyst-ratings" target="_blank" rel="noreferrer noopener">$415에서 $412로 하향 조정</a>한 후 9.45% 하락했다.
6. 브라운 포먼(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>)의 주식은 미국 총기 건강 책임자 머시가 알코올 소비가 암 위험을 증가시킬 수 있다는 경고를 발표한 후 8.20% 하락했다.
7. 트립닷컴 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)의 주식은 씨티그룹이 주식의 가격 예측을 <a href="https://www.benzinga.com/quote/tcom/analyst-ratings" target="_blank" rel="noreferrer noopener">$73에서 $78로 상향 조정</a>한 후 7.47% 하락했다.
8. 포멘토 이코노미코 멕시카노 S.A.B. de C.V.(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>)의 주식은 미국 공중보건국장인 비벡 머시(Vivek Murthy)가 알코올 소비와 관련된 암 위험 증가에 대해 경고한 후 7.47% 하락했다.
9. 오로라 이노베이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>)의 주식은 9.47% 하락했다.
추가 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%A6%AC%EB%B9%84%EC%95%88-%EB%AA%A8%EB%B9%8C%EC%95%84%EC%9D%B4-%EB%B0%8F-arm%EC%9D%80-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EA%B3%A0-%EC%84%B1%EA%B3%BC%EB%A5%BC-%EB%B3%B4%EC%97%AC%EC%A4%80-10/" target="_blank" rel="noopener">리비안, 모빌아이 및 Arm은 지난주 최고 성과를 보여준 10개 대형주 중 일부 (12월 30일-1월 3일)</a></li>
</ul>
이미지 출처: Tesla
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요. 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

CNN 머니 공포와 탐욕 지수(CNN Money Fear and Greed index)가 전체 시장 심리가 하락했음을 보여주었고, 월요일에는 &#8220;공포&#8221; 구역에 머물렀다.
월요일에 미국 주식은 하락세로 마감했다. 다우존스 지수는 250포인트 이상 하락하면서 투자자들이 중요한 대통령 선거를 대비하는 모습이 나타났다.
경제 지표 측면에서, 미국의 공장 주문이 전월 대비 0.5% 감소하여 9월에 5,842억 달러로 집계되었다. 이는 수정된 8월의 0.8% 감소와 비교된다.
얌 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)의 주가는 회사가 예상보다 좋은 3분기 EPS와 매출을 발표한 후 월요일에 7% 이상 상승했다.
엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)의 주가는 연초 대비 약 182% 상승하고, 인텔(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)의 주가는 올해 가치가 절반 이상 하락했다.
대부분의 S&amp;P 500 섹터가 부정적인 마감세를 보였으며, 공공 서비스, 통신 서비스 및 금융 주식이 월요일에 가장 큰 손실을 기록했습니다. 그러나 에너지와 부동산 주식은 전체 시장 추세와 반대로 상승하여 세션을 마감했습니다.
다우 존스는 월요일에 약 258포인트 하락하여 41,794.60으로 마감했습니다. S&amp;P 500은 0.28% 하락하여 5,712.69로, 나스닥 종합지수는 0.33% 하락하여 18,179.98로 월요일 세션을 마감했습니다.
투자자들은 아처 대니얼스 미들랜드 컴퍼니(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>), 얌 브랜즈(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) 및 커민스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>)의 실적 발표를 기다리고 있다.
CNN 비즈니스 공포와 탐욕 지수란 무엇인가요?
현재 42.9의 지수는 월요일에 &#8220;공포&#8221; 구역에 남아 있었으며, 이전 지수는 44.5였다.
공포와 탐욕 지수는 현재 시장 심리를 측정한 것이다. 이는 높은 공포가 주가에 하락 압력을 가하고, 높은 탐욕이 그 반대의 효과를 미친다는 전제에 기반한다. 이 지수는 7개의 동등 가중 지표를 기반으로 계산된다. 지수는 0에서 100까지 범위가 있으며, 0은 최대 공포를, 100은 최대 탐욕을 나타낸다.
다음 읽기: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41713185/top-4-tech-and-telecom-stocks-that-may-collapse-this-month">이번 달에 급락 가능성이 있는 상위 4개 기술 및 통신 주식</a></li>
</ul>
사진 제공: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Pre-Market Outlook

INTC

투자자들이 美 대선을 대비하며 다우존스 지수가 250포인트 하락, '탐욕 지수'는 '공포' 영역에

지난주, 중국 중앙은행이 은행의 지급준비율(RRR)을 50bp(베이시스 포인트) 또는 0.5%포인트 인하하기로 발표하면서 미국에 상장된 중국 기업들의 <a href="https://www.benzinga.com//node/41065178" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">주가가 전반적으로</a> 상승했다.
지난주 가장 좋은 성과를 보인 10개의 대형 주식이 있다. 여러분의 포트폴리오에 포함되어 있나요?
1. JD닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>)의 주식은 중국 인민은행이 은행들이 보유해야 하는 현금의 양을 줄이기로 발표하고 <a href="https://www.benzinga.com//node/41062614" target="_blank" rel="noreferrer noopener">부동산 시장 지원 계획</a>을 발표한 후 39.75% 급등했다.
2. KE 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>)의 주식은 중국이 부양책의 일환으로 최대 2,840억 달러의 국채를 발행할 것이라는 보도가 나온 후 39.18% 상승했다.
3. PDD 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>)의 주식은 중국이 부양책의 일환으로 최대 2,840억 달러의 <a href="https://www.benzinga.com//node/41026720" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">국채를 발행할 것</a>이라는 보도가 나온 후 35.52% 상승했다.
4. 리버티 브로드밴드 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBRDA#NASDAQ">LBRDA</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/41015233" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">차터 커뮤니케이션즈</a>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>)의 특별위원회에 반대 제안을 전달했다고 발표한 후 31.74% 상승했다.
5. 염 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)의 주식은 중국의 부책 발표로 인해 27.64% 상승했다.
6. H 월드 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTHT#NASDAQ">HTHT</a>)의 주식은 중국 주식의 핀 액션으로 인해 26.43% 상승했다.
7. 트립닷컴 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>)의 주식은 중국 주식의 핀 액션으로 인해 지난 주 26.02% 상승했다.
8. 니오(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>)의 주식은 정부의 부양책 발표로 인해 중국 주식의 랠리에 동참하면서 23.48% 상승했다.
9. 윈 리조트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>)의 주식은 모건 스탠리가 중립에서 비중 확대 등급으로 상향 조정하고 목표 주가를 97달러에서 104달러로 <a href="https://www.benzinga.com/quote/WYNN/analyst-ratings" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">상향 조정</a>한 후 22.47% 상승했다.
10. 바이두(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>)의 주식은 정부의 부양책 발표로 인해 중국 주식의 랠리에 동참하면서 21.95% 상승했다.
알리바바 그룹 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>)와 리 오토(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>)도 지난주 중국 주식의 랠리에 동참하여 각각 20% 이상 상승했다.
추가 읽기:
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EB%A6%AC%EC%A0%9C%EB%84%A4%EB%A1%A0%EA%B3%BC-%EC%8A%88%ED%8D%BC-%EB%A7%88%EC%9D%B4%ED%81%AC%EB%A1%9C%EB%8A%94-%EC%A7%80%EB%82%9C%EC%A3%BC-%EC%B5%9C%EC%95%85%EC%9D%98-%EC%84%B1%EA%B3%BC%EB%A5%BC/" target="_blank" rel="noopener">리제네론 파마, 슈퍼 마이크로 컴퓨터 및 글로벌 페이먼츠는 지난주 최악의 성과를 보인 10개 대형주 중 일부 (9월 23일-9월 27일)</a></li>
</ul>
Photo by Eric Prouzet on Unsplash
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Emerging Markets

BEKE

BIDU

CHTR

HTHT

LBRDA

WYNN

중국 주식 우세 - JD닷컴과 PDD는 지난주 최고 성과를 보여준 10개 대형주 중 일부 (9월 23일-9월 27일)

글로벌 시장은 극심한 변동성을 겪고 있으며, <a href="https://www.benzinga.com/markets/equities/24/08/40152271/mohamed-el-erian-grant-cardone-and-matt-weller-warn-of-deepening-global-market-selloff-as-yen-ri" target="_blank" rel="noopener" data-google-interstitial="false">일본의 닛케이 225 지수가 밤새 13% 급락한</a> 이후 월스트리트의 블랙 먼데이는 불가피한 것처럼 보였지만, 주가 지수는 뉴욕 정오 거래를 통해 장 초반 손실을 제한하려고 시도하고 있다.
이 변곡점은 7월의 서비스 부문 활동 조사에서 6월보다 개선된 여건과 예상보다 강한 확장세를 보여 미국 <a href="https://www.benzinga.com/news/econ-s/24/08/40161832/us-services-activity-returns-to-growth-in-july-global-market-selloff-stalls-are-recession-fears-over" target="_blank" rel="noopener" data-google-interstitial="false">경기 침체</a>에 대한 우려가 완화된 이후에 발생했다.
7월에는 ISM 서비스 구매관리자지수(PMI)가 48.8%에서 51.4%로 상승해 예상치인 51% 상승을 뛰어넘는 등 미국 서비스 부문의 기업 심리가 다시 확장세를 보였다.
ISM 데이터가 발표되기 전에 트레이더들은 오스탄 굴스비 시카고 연준 총재가 CNBC 인터뷰에서 모든 것이 논의될 수 있다고 말한 후 회의 중 연준 금리 인하를 추측했다.
이후 이 데이터가 발표되자, CME 그룹의 페드워치(FedWatch) 도구에 따르면 시장에 내재된 50베이시스포인트(bp) 금리 인하 가능성은 100%에서 약 80%로 감소한 반면, 25bp 인하 가능성은 약 0%에서 20%로 증가했다. .
S&amp;P 500은 4% 이상 하락한 5,120포인트에서 개장한 후 오후 12시 30분까지 손실폭을 소폭 줄인 5,233포인트에 거래되었다. 이는 전 날에 비해 2.1% 하락한 것이다.
기술주 중심의 나스닥 100, 다우존스가 추적하는 우량주 그리고 소형주에서도 비슷한 움직임이 관찰되었다.
금리 확률이 바뀌면서 채권 상승이 멈췄고 국채 수익률은 모든 만기에서 상승했다. 2년 만기 국채 수익률은 거래시간 초반 3.65%까지 하락한 뒤 4bp 오른 3.92%에 거래됐다.
인기 있는 iShares 20+Year Treasury Bond ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>)는 7회 연속 상승세를 보인 이후 변동이 없었다.
비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)은 뉴욕에서 오전 9시 30분에 처음으로 15% 하락했지만, 이후 오전 9시 30분부터 오후 12시 30분까지 10% 반등하여 일일 손실률을 5.9%로 줄였다.
원자재는 금과 석유가 각각 1.5%, 1.3% 하락하는 등 전반적으로 하락세를 보였다. 은은 두 달 만에 최악의 세션으로 거의 5% 급락했다.
<h2 class="wp-block-heading">월요일 주요 미국 지수 및 ETF</h2>
<figure class="wp-block-table is-style-stripes">
<table style="overflow:auto; height: 90px; display: block;">
<tbody>
<tr>
<td>주요 지수</td>
<td>가격</td>
<td>1일 변동률</td>
</tr>
<tr>
<td>다우존스</td>
<td>38,918.07</td>
<td>-2.1 %</td>
</tr>
<tr>
<td>나스닥 100</td>
<td>18,040.81</td>
<td>-2.2%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,226.62</td>
<td>-2.2%</td>
</tr>
<tr>
<td>러셀 2000</td>
<td>2,055.96</td>
<td>-2.4%</td>
</tr>
</tbody>
</table><figcaption class="wp-element-caption">동부 표준시 12시 43분 기준 업데이트됨</figcaption></figure>
Benzinga Pro의 데이터에 따르면:
<ul>
<li>SPDR S&amp;P 500 ETF Trust(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)는 520.50달러로 2.2% 하락했다.</li>
<li>SPDR Dow Jones Industrial Average(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)는 388.75달러로 2.1% 하락했다.</li>
<li>기술주 중심의 Invesco QQQ Trust Series(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)는 438.40달러로 2.3% 하락했다.</li>
<li>iShares Russell 2000 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>)는 203.26달러로 2.7% 하락했다.</li>
<li>부문별로는, Real Estate Select Sector SPDR Fund(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)가 1.2% 감소로 가장 작은 하락세를 보인 반면, Technology Select Sector SPDR Fund(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)는 2.8% 하락하여 가장 큰 하락세를 보였다.</li>
</ul>
<h2 class="wp-block-heading">월요일의 개별 종목 움직임</h2>
<ul>
<li>켈라노바(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>)의 주가는 비공개 기업인 마즈(Mars)가 프링글스(Pringles) 제조업체를 인수하기 위한 사전 협상을 진행 중이라고 월스트리트 저널(WSJ)이 보도한 후 14% 이상 급등했다.</li>
</ul>
실적에 대한 반응으로 움직인 주식들은 다음과 같다:
<ul>
<li>바이오엔텍 SE(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) (2.54% 하락),</li>
<li>칼라일 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CG#NASDAQ">CG</a>) (8% 하락),</li>
<li>타이슨 푸드(NYSW:TSN) (4% 상승)</li>
</ul>
마감 이후에 실적 발표는은 다음과 같다: 애드트랜 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>), AVIS 버짓 그룹(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAR#NASDAQ">CAR</a>), 다이아몬드백 에너지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>), CSX(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>), 나비타스 반도체(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>), J&amp;J 스낵 푸드(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JJSF#NASDAQ">JJSF</a>), 팔란티어 테크놀로지스NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) 및 염 차이나 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NASDAQ">YUMC</a>).
Photo: Shutterstock
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Cryptocurrency

Mid Cap

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Commodities

Small Cap

Treasuries

Econ #s

Federal Reserve

Tech

ETFs

$BTC

ADTN

BNTX

FANG

JJSF

NVTS

PLTR

XLRE

미국 주식 시장은 서비스 지표의 확장에 블랙 먼데이의 하락을 축소, 채권 상승은 정체

화요일 오전 미국 주식 선물이 하락세를 보이면서 오늘 투자자들의 관심을 끌 수 있는 주식은 다음과 같다:
<ul>
<li><a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>의 데이터에 따르면 월스트리트는 코카콜라(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>)가 개장 전에 102억 9천만 달러의 매출과 주당 65센트의 분기 이익을 보고할 것으로 예상하고 있다. 코카콜라 주가는 시간외 거래에서 0.2% 하락한 61.95달러를 기록했다.</li>
<li>얌 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)는 1분기에 긍정적인 이익을 발표했지만 매출은 기대에 못 미쳤다. 얌 차이나 주가는 시간외 거래에서 3.4% 하락한 38.70달러를 기록했다.</li>
<li>분석가들은맥도날드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>)가 57억 5천만 달러의 매출과 주당 이익으로 2.54달러로 기록할 것으로 예상하고 있다. 회사는 시장 개장 전에 시적을 발표할 예정이다. 맥도날드 주가는 시간외 거래에서 0.2% 상승한 274.00달러를 기록했다.</li>
</ul>
저희의 <a href="https://www.benzinga.com/premarket/">개장 전 시장 뉴스를 확인하세요</a>
<ul>
<li>센사타 테크놀러지스 홀딩(NYSE:<a class="ticker" style="font-size: revert;" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>)는 월요일 1분기에 예상보다 강한 결과를 보고했다. 회사는 제프 코트(Jeff Cote)가 CEO 겸 사장직을 은퇴할 것이라고 말했다. 센사타는 2분기 조정 수익이 주당 89~95센트, 매출 10억 2,500만~10억 5,500만 달러가 될 것으로 예상한다고 밝혔다. 센사타의 주가는 시간외 거래에서 17.6% 상승한 42.05달러를 기록했다.</li>
<li>분석가들은 아마존닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)이 시장 마감 후 1,331억 달러의 매출과 주당 77센트의 분기 이익을 기록할 것으로 예상한다. 아마존 주가는 시간외 거래에서 0.7% 상승한 182.26달러를 기록했다.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38509641/mcdonalds-likely-to-report-higher-q1-earnings-here-are-the-recent-forecast-changes-from-wall-street">맥도날드, Q1 매출 확대 예상… 월스트리트 최고의 분석가들의 최신 예측 변화</a>

코카콜라, 아마존 그리고 화요일 주목해야 할 주식 3종목

월요일 아침 미국 주식 선물이 상승하면서 오늘 투자자의 관심을 끌 수 있는 일부 주식은 다음과 같다:
벤징가 프로의 데이터에 따르면 월스트리트는 도미노 피자(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>)가 개장 전 매출 10억 8천만 달러, 주당 3.39달러의 분기 이익을 보고할 것으로 예상하고 있다. 도미노의 주가는 시간 외 거래에서 0.3% 상승한 500.39달러를 기록했다.
분석가들은 얌 차이나 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)가 30억 5천만 달러의 매출과 주당 65센트의 분기 이익을 기록할 것으로 예상하고 있다. 이 회사는 시장이 마감된 후 수익을 발표할 예정이다. 얌 차이나의 주가는 시간 외 거래에서 0.7% 상승한 39.91달러를 기록했다.
테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)는 EV 판매 및 마진 하락에 따른 비용 절감을 위해 이달 초 회사가 발표한 10% 정리해고의 일환으로 네바다 시설에서 직원 693명을 해고할 예정인 것으로 알려졌다. 이 회사는 또한 출시 불과 며칠 만에 미국에서 새로운 모델 3 퍼포먼스의 가격을 1,000달러 인상했다. 테슬라 주가는 시간 외 거래에서 0.4% 상승한 168.93달러를 기록했다.
시장이 개장하기 전에 온 세미컨덕터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>)은 매출 18억 5천만 달러, 주당 1.04달러의 분기 이익을 보고할 것으로 예상된다. 온 세미컨덕터의 주가는 시간 외 거래에서 0.7% 상승한 68.50달러를 기록했다.
분석가들은 NXP 세미컨덕터(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>)가 마감 후 31억 3천만 달러의 매출과 31억 3천만 달러의 분기 이익을 주당 3.16달러로 기록할 것으로 예상된다. NXP 반도체 주가는 시간외 거래에서 0.5% 상승한 243.80달러를 기록했다.

Comments

Yum China Holdings

뉴스

에 대한 최신 뉴스 Yum China Holdings (NYSE:YUMC) 주식

일요일, 4월 20, 2025

일요일, 4월 13, 2025

일요일, 1월 05, 2025

화요일, 11월 05, 2024

일요일, 9월 29, 2024

월요일, 8월 05, 2024

화요일, 4월 30, 2024

월요일, 4월 29, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌